Navigation Links
Asthma Meds May Be Linked to Irregular Heartbeat
Date:5/23/2012

TUESDAY, May 22 (HealthDay News) -- New research suggests that young asthma patients who use drugs known as inhaled anticholinergics -- such as ipratropium [Atrovent] -- could be more likely than others to suffer from potentially dangerous irregular heartbeat.

However, the increased risk was not seen for some types of anticholinergics.

"Obviously, this finding raises concern because of the recent interest in use of anticholinergics in asthma," study author Todd Lee of the University of Illinois at Chicago, said in a news release from the American Thoracic Society.

Still, "while we did find an increase in the risk of events associated with the use of anticholinergics, the overall number of events we found was relatively small," Lee said. "Therefore, the absolute risk of an event for an individual patient is relatively low."

Asthma patients use anticholinergic drugs when they have flare-ups to get quick relief. The medications have shown promise for use in the long term to prevent exacerbations, the release noted.

But based on research with patients who have chronic obstructive pulmonary disease, scientists wonder if the drugs could boost the risk of heart problems. In the new study, researchers studied data on more than 280,000 asthma patients aged 5 to 24. They found 7,656 new users of asthma drugs who had at least 6 months' usage and compared them to about 76,000 other patients.

The researchers found that those who used the drugs faced a risk of irregular heartbeat. The abstract of the study doesn't say how many developed the problem, but reports that the anticholinergic users had 1.56 times the risk of non-users.

The type of anticholingeric drug used made a difference. No signficant risk was seen for tiotropium (Spiriva) or with ipratropium when it was combined with other asthma drugs called short-acting beta agonists, like albuterol.

The increased risk was only seen with higher anticholinergic doses.

It's also not clear if the drugs are directly responsible for any increased risk. While the study found an association between anticholinergic use and irregular heartbeats, it did not prove a cause-and-effect relationship.

Dr. Alan Baptist, an assistant professor of allergy and immunology at the University of Michigan, said the study is useful, but cautioned that the patients who took the drugs -- which are typically considered a secondary option after other drugs -- might differ from other asthma patients.

"For example, patients are sometimes given ipratropium because they complain of 'racing heart' with albuterol, the first-line therapy," Baptist said. "Therefore, perhaps those patients given anticholinergics were at an increased baseline risk for an arrhythmia even before they received the anticholinergic."

What should doctors and patients do? "Always consider the risks and benefits of medications, step down medication level when asthma control is reached, and use the lowest dose possible," he said.

The study was scheduled for release Tuesday at an American Thoracic Society conference in San Francisco. The data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

More information

For more about asthma, check the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCES: Alan P. Baptist, assistant professor, allergy and immunology, University of Michigan, Ann Arbor; May 22, 2012, presentation, American Thoracic Society meeting, San Francisco


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Children failing asthma therapy may have severe asthma with fungal sensitization
2. Baseline characteristics of children with mild persistent asthma predict response to ICS
3. Identifying asthma patients who tolerate lower doses of steroids remains problematic
4. Breathing Smog While Pregnant May Worsen Asthma in Offspring
5. Prenatal exposure to pollution especially dangerous for children with asthma
6. Asthma Cases Continue to Rise in U.S., Affecting Millions
7. Inhaled Steroids Lead to Big Drop in Asthma Deaths at Texas Hospital: Study
8. ICU stays for worst asthma drop 74 percent, review finds
9. Seniors Undertreated for Asthma, and Many Skip Inhalers: Study
10. Many Asthmatic Kids Harmed by Secondhand Smoke: Study
11. Secondhand smoke continues to vex children with asthma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Asthma Meds May Be Linked to Irregular Heartbeat
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: